COMPARISON OF THE VIBRIOCIDAL ANTIBODY-RESPONSE IN CHOLERA DUE TO VIBRIO-CHOLERAE-O139 BENGAL WITH THE RESPONSE IN CHOLERA DUE TO VIBRIO-CHOLERAE-O1

被引:82
作者
QADRI, F [1 ]
MOHI, G [1 ]
HOSSAIN, J [1 ]
AZIM, T [1 ]
KHAN, AM [1 ]
SALAM, MA [1 ]
SACK, RB [1 ]
ALBERT, MJ [1 ]
SVENNERHOLM, AM [1 ]
机构
[1] GOTHENBURG UNIV, DEPT MED MICROBIOL & IMMUNOL, GOTHENBURG, SWEDEN
关键词
D O I
10.1128/CDLI.2.6.685-688.1995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vibrio cholerae serogroup 0139, now considered to be the second organism capable of causing epidemic severe dehydrating cholera, contains a capsular polysaccharide which makes it difficult for it to be used in the conventional vibriocidal antibody assay optimized for V. cholerae 01. After modification of the procedure, which involved the use of specific bacterial strains, a lower bacterial inoculum, and increased amounts of complement, the vibriocidal antibody responses to V. cholerae 0139 were measured in acute- and convalescent-phase sera from 33 V. cholerae 0139-infected and 18 V. cholerae 01-infected patients and in single serum samples from 20 healthy control subjects. The responses in these individuals to V. cholerae 01 strains were also determined. Significant elevations in the homologous antibody response were found only in the convalescent-phase sera from both groups of patients with cholera. These findings may explain the basis for the lack of heterologous protection between the two serogroups of V. cholerae. Healthy controls had higher background levels of vibriocidal antibody to V. cholerae 01 than to V. cholerae 0139.
引用
收藏
页码:685 / 688
页数:4
相关论文
共 23 条
[11]   VIBRIO-CHOLERAE O139 SYNONYM BENGAL IS CLOSELY-RELATED TO VIBRIO-CHOLERAE EL-TOR BUT HAS IMPORTANT DIFFERENCES [J].
JOHNSON, JA ;
SALLES, CA ;
PANIGRAHI, P ;
ALBERT, MJ ;
WRIGHT, AC ;
JOHNSON, RJ ;
MORRIS, JG .
INFECTION AND IMMUNITY, 1994, 62 (05) :2108-2110
[12]  
JONSON G, UNPUB
[13]   SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD-103 AND CVD-103-HGR [J].
LEVINE, MM ;
HERRINGTON, D ;
LOSONSKY, G ;
TALL, B ;
KAPER, JB ;
KETLEY, J ;
TACKET, CO ;
CRYZ, S .
LANCET, 1988, 2 (8609) :468-470
[14]  
MCINTYRE OR, 1964, J INFECT DIS, V135, P886
[15]   CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF VIBRIO-CHOLERAE O139 BENGAL INFECTION IN NORTH-AMERICAN VOLUNTEERS [J].
MORRIS, JG ;
LOSONSKY, GE ;
JOHNSON, JA ;
TACKET, CO ;
NATARO, JP ;
PANIGRAHI, P ;
LEVIN, MM .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :903-908
[16]  
MOSLEY WH, 1969, TEX REP BIOL MED, VS 27, P227
[17]   PRODUCTION, CHARACTERIZATION, AND APPLICATION OF MONOCLONAL-ANTIBODIES TO VIBRIO-CHOLERAE O139 SYNONYM BENGAL [J].
QADRI, F ;
AZIM, T ;
CHOWDHURY, A ;
HOSSAIN, J ;
SACK, RB ;
ALBERT, MJ .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (01) :51-54
[18]   MUCOSAL ANTITOXIC AND ANTIBACTERIAL IMMUNITY AFTER CHOLERA DISEASE AND AFTER IMMUNIZATION WITH A COMBINED B-SUBUNIT-WHOLE CELL VACCINE [J].
SVENNERHOLM, AM ;
JERTBORN, M ;
GOTHEFORS, L ;
KARIM, AMMM ;
SACK, DA ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (06) :884-893
[19]  
SWERDLOW DL, 1993, LANCET, V342, P382, DOI 10.1016/0140-6736(93)92806-5
[20]   THE VIBRIO-CHOLERAE O139 SEROGROUP ANTIGEN INCLUDES AN O-ANTIGEN CAPSULE AND LIPOPOLYSACCHARIDE VIRULENCE DETERMINANTS [J].
WALDOR, MK ;
COLWELL, R ;
MEKALANOS, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11388-11392